You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
拓新藥業(301089.SZ):新鄉製藥胞磷膽鹼原料藥獲得上市申請批準通知書
格隆匯 07-07 18:01

格隆匯7月7日丨拓新藥業(301089.SZ)公佈,近日,拓新藥業集團股份有限公司全資子公司新鄉製藥股份有限公司(以下簡稱“新鄉製藥”)胞磷膽鹼原料藥收到國家藥品監督管理局簽發的《化學原料藥上市申請批準通知書》(受理號:CYHS2360697),並在國家藥品監督管理局藥品審評中心官方網站公示。

胞磷膽鹼作爲臨牀常用的神經保護劑與腦代謝激活劑,其核心藥理作用在於改善腦功能、促進神經修復,臨牀適用範圍涵蓋腦損傷、腦血管疾病、神經系統退行性疾病等患者羣體。該藥品通過提高腦細胞能量代謝效率、穩定細胞膜結構、加速受損神經組織修復等機制發揮作用,在腦卒中、腦外傷等疾病的輔助治療中具有重要臨牀價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account